Improving survival from metastatic, recurrent, or persistent cervical cancer. Mileshkin LR, Manoharan S. Lancet 2023 Dec 1:S0140-6736(23)02690-9. doi: 10.1016/S0140-6736(23)02690.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mileshkin LR, Manoharan S. Improving survival from metastatic, recurrent, or persistent cervical cancer. Lancet 2023 Dec 1:S0140-6736(23)02690-9. doi: 10.1016/S0140-6736(23)02690.
PMID: 38048788